Latest News about BIIB
Recent news which mentions BIIB
Is This Biotech Stock Worth the Trouble?
April 23, 2022
From Motley Fool
Does Eli Lilly's Future Depend on its Alzheimer's Drug?
April 23, 2022
From Motley Fool
Is Biogen Stock a Buy Now?
April 21, 2022
From Motley Fool
Down 16% Since October, Could This Stock Make a Turnaround?
April 21, 2022
Tickers
BIIB
From Motley Fool
7 Potential Biotech Stocks Buyout Targets in 2022
April 21, 2022
From InvestorPlace
From Benzinga
3 Biotech Stocks That Could Help Make You a Fortune
April 14, 2022
From Motley Fool
Biogen’s Aduhelm Crashes the Biotech Sector
April 13, 2022
From InvestorPlace
From InvestorPlace
Why Is Trevi Therapeutics (TRVI) Stock On the Move Today?
April 08, 2022
From InvestorPlace
Why Is Biogen (BIIB) Stock in the Spotlight Today?
April 08, 2022
From InvestorPlace
From Benzinga
From InvestorPlace
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
April 08, 2022
Tickers
BIIB
From Benzinga
3 Healthcare Stocks That Could Help Set You Up for Life
April 07, 2022
From Motley Fool
From Motley Fool
From Benzinga
From Motley Fool
Why I Sold Kohl’s Corporation Despite Possible Buyout Deal
March 22, 2022
From InvestorPlace
From Benzinga
2 Red Flags for Biogen's Future
March 22, 2022
From Motley Fool
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
March 15, 2022
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.